Cargando…

Clinical expertise, advocacy and enhanced autonomy – Acceptability of a pharmacist-facilitated medicines review intervention for community-dwelling Māori older adults

BACKGROUND: Pharmacist-facilitated medicines reviews are effective at identifying medicines-related problems and can improve the appropriate use of medicines in older adults. Current services in Aotearoa New Zealand (NZ) are not developed specifically for Māori (Indigenous people of NZ) and may incr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hikaka, Joanna, Jones, Rhys, Hughes, Carmel, Amende, Hunter, Connolly, Martin J., Martini, Nataly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031370/
https://www.ncbi.nlm.nih.gov/pubmed/35481115
http://dx.doi.org/10.1016/j.rcsop.2021.100010
_version_ 1784692373226258432
author Hikaka, Joanna
Jones, Rhys
Hughes, Carmel
Amende, Hunter
Connolly, Martin J.
Martini, Nataly
author_facet Hikaka, Joanna
Jones, Rhys
Hughes, Carmel
Amende, Hunter
Connolly, Martin J.
Martini, Nataly
author_sort Hikaka, Joanna
collection PubMed
description BACKGROUND: Pharmacist-facilitated medicines reviews are effective at identifying medicines-related problems and can improve the appropriate use of medicines in older adults. Current services in Aotearoa New Zealand (NZ) are not developed specifically for Māori (Indigenous people of NZ) and may increase health disparities between Māori and non-Māori. We developed a medicines review intervention for and with Māori older adults, and tested it in a feasibility study. OBJECTIVE: To assess patient acceptability of a pharmacist-facilitated medicines review intervention for Māori older adults. METHODS: The intervention consisted of a medicines education session (pharmacist and participant) and an optional medicines optimisation session (pharmacist, participant, and prescriber). Participant acceptability was assessed post-intervention using a structured telephone interview developed specifically for this study. Participants responded to statements using a five-point Likert scale (strongly agree-strongly disagree; numerical analysis/reporting) which focused on the topics of power/control, support mechanisms, intervention content and delivery, and perceived usefulness. Open-ended questions relating to the intervention value and suggestions for improvement were analysed using general inductive analysis. RESULTS: Seventeen participants took part in the feasibility study from December 2019–March 2020 and all completed the acceptability interview. Participants perceived the intervention content and mode of delivery to be appropriate, and that their power and control over their medicines and health improved and as did their confidence in self-management. Five themes were generated: medicines knowledge from a trusted professional, increased advocacy, ‘by Māori, for Māori’, increased confidence and control, and financial and resource implications. CONCLUSION: A pharmacist-facilitated medicines review intervention for Māori older adults developed by Māori, for Māori, was acceptable to patient participants. Participants valued the clinical expertise and advocacy provided by the pharmacist, and the increase in medicines knowledge, control and autonomy. Participants wanted the service to continue on an ongoing basis.
format Online
Article
Text
id pubmed-9031370
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-90313702022-04-26 Clinical expertise, advocacy and enhanced autonomy – Acceptability of a pharmacist-facilitated medicines review intervention for community-dwelling Māori older adults Hikaka, Joanna Jones, Rhys Hughes, Carmel Amende, Hunter Connolly, Martin J. Martini, Nataly Explor Res Clin Soc Pharm Article BACKGROUND: Pharmacist-facilitated medicines reviews are effective at identifying medicines-related problems and can improve the appropriate use of medicines in older adults. Current services in Aotearoa New Zealand (NZ) are not developed specifically for Māori (Indigenous people of NZ) and may increase health disparities between Māori and non-Māori. We developed a medicines review intervention for and with Māori older adults, and tested it in a feasibility study. OBJECTIVE: To assess patient acceptability of a pharmacist-facilitated medicines review intervention for Māori older adults. METHODS: The intervention consisted of a medicines education session (pharmacist and participant) and an optional medicines optimisation session (pharmacist, participant, and prescriber). Participant acceptability was assessed post-intervention using a structured telephone interview developed specifically for this study. Participants responded to statements using a five-point Likert scale (strongly agree-strongly disagree; numerical analysis/reporting) which focused on the topics of power/control, support mechanisms, intervention content and delivery, and perceived usefulness. Open-ended questions relating to the intervention value and suggestions for improvement were analysed using general inductive analysis. RESULTS: Seventeen participants took part in the feasibility study from December 2019–March 2020 and all completed the acceptability interview. Participants perceived the intervention content and mode of delivery to be appropriate, and that their power and control over their medicines and health improved and as did their confidence in self-management. Five themes were generated: medicines knowledge from a trusted professional, increased advocacy, ‘by Māori, for Māori’, increased confidence and control, and financial and resource implications. CONCLUSION: A pharmacist-facilitated medicines review intervention for Māori older adults developed by Māori, for Māori, was acceptable to patient participants. Participants valued the clinical expertise and advocacy provided by the pharmacist, and the increase in medicines knowledge, control and autonomy. Participants wanted the service to continue on an ongoing basis. Elsevier 2021-04-18 /pmc/articles/PMC9031370/ /pubmed/35481115 http://dx.doi.org/10.1016/j.rcsop.2021.100010 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Hikaka, Joanna
Jones, Rhys
Hughes, Carmel
Amende, Hunter
Connolly, Martin J.
Martini, Nataly
Clinical expertise, advocacy and enhanced autonomy – Acceptability of a pharmacist-facilitated medicines review intervention for community-dwelling Māori older adults
title Clinical expertise, advocacy and enhanced autonomy – Acceptability of a pharmacist-facilitated medicines review intervention for community-dwelling Māori older adults
title_full Clinical expertise, advocacy and enhanced autonomy – Acceptability of a pharmacist-facilitated medicines review intervention for community-dwelling Māori older adults
title_fullStr Clinical expertise, advocacy and enhanced autonomy – Acceptability of a pharmacist-facilitated medicines review intervention for community-dwelling Māori older adults
title_full_unstemmed Clinical expertise, advocacy and enhanced autonomy – Acceptability of a pharmacist-facilitated medicines review intervention for community-dwelling Māori older adults
title_short Clinical expertise, advocacy and enhanced autonomy – Acceptability of a pharmacist-facilitated medicines review intervention for community-dwelling Māori older adults
title_sort clinical expertise, advocacy and enhanced autonomy – acceptability of a pharmacist-facilitated medicines review intervention for community-dwelling māori older adults
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031370/
https://www.ncbi.nlm.nih.gov/pubmed/35481115
http://dx.doi.org/10.1016/j.rcsop.2021.100010
work_keys_str_mv AT hikakajoanna clinicalexpertiseadvocacyandenhancedautonomyacceptabilityofapharmacistfacilitatedmedicinesreviewinterventionforcommunitydwellingmaoriolderadults
AT jonesrhys clinicalexpertiseadvocacyandenhancedautonomyacceptabilityofapharmacistfacilitatedmedicinesreviewinterventionforcommunitydwellingmaoriolderadults
AT hughescarmel clinicalexpertiseadvocacyandenhancedautonomyacceptabilityofapharmacistfacilitatedmedicinesreviewinterventionforcommunitydwellingmaoriolderadults
AT amendehunter clinicalexpertiseadvocacyandenhancedautonomyacceptabilityofapharmacistfacilitatedmedicinesreviewinterventionforcommunitydwellingmaoriolderadults
AT connollymartinj clinicalexpertiseadvocacyandenhancedautonomyacceptabilityofapharmacistfacilitatedmedicinesreviewinterventionforcommunitydwellingmaoriolderadults
AT martininataly clinicalexpertiseadvocacyandenhancedautonomyacceptabilityofapharmacistfacilitatedmedicinesreviewinterventionforcommunitydwellingmaoriolderadults